Cargando…

Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2

Vasohihibin‐2 (VASH2) is a homolog of vasohibin‐1 (VASH1) and is overexpressed in various cancers. Vasohihibin‐2 acts on both cancer cells and cancer microenvironmental cells. Previous analyses have shown that VASH2 promotes cancer progression and abrogation of VASH2 results in significant anticance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horie, Sachiko, Suzuki, Yasuhiro, Yamamoto, Tsuyoshi, Obika, Satoshi, Mohri, Kohta, Kiyota, Chizuru, Ren, Qin, Warashina, Shota, Wada, Yasuhiro, Watanabe, Yasuyoshi, Mukai, Hidefumi, Sato, Yasufumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475766/ https://www.ncbi.nlm.nih.gov/pubmed/37430466 http://dx.doi.org/10.1111/cas.15897

Ejemplares similares

Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
por: Suenaga, Kaori, et al.
Publicado: (2014)

The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010)

Age‐associated downregulation of vasohibin‐1 in vascular endothelial cells
por: Takeda, Eichi, et al.
Publicado: (2016)

Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2021)

Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis
por: Kitahara, Shuji, et al.
Publicado: (2014)

Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
por: Ito, Soichi, et al.
Publicado: (2013)

Superior Silencing by 2′,4′-BNA(NC)-Based Short Antisense Oligonucleotides Compared to 2′,4′-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2012)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Requisite role of vasohibin‐2 in spontaneous gastric cancer formation and accumulation of cancer‐associated fibroblasts
por: Suzuki, Yasuhiro, et al.
Publicado: (2017)

Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
por: Wada, Fumito, et al.
Publicado: (2021)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
por: Koyanagi, Takahiro, et al.
Publicado: (2017)

Exogenous Vasohibin-2 Exacerbates Angiotensin II-Induced Ascending Aortic Dilation in Mice
por: Okuyama, Michihiro, et al.
Publicado: (2019)

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity
por: Sato, Yasufumi
Publicado: (2018)

Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling
por: Norita, Rie, et al.
Publicado: (2017)

Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells
por: KOYANAGI, TAKAHIRO, et al.
Publicado: (2013)

The crystal structure of the tetrameric human vasohibin-1–SVBP complex reveals a variable arm region within the structural core
por: Ikeda, Akihito, et al.
Publicado: (2020)

Angiogenesis Inhibitor Vasohibin-1 Enhances Stress Resistance of Endothelial Cells via Induction of SOD2 and SIRT1
por: Miyashita, Hiroki, et al.
Publicado: (2012)

Solid-Phase Synthesis of Boranophosphate/Phosphorothioate/Phosphate Chimeric Oligonucleotides and Their Potential as Antisense Oligonucleotides
por: Takahashi, Yuhei, et al.
Publicado: (2021)

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2012)

High preoperative plasma vasohibin‐1 concentration predicts better prognosis in patients with non–small cell lung carcinoma
por: Watanabe, Tatsuaki, et al.
Publicado: (2018)

Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
por: Miyake, Hiromasa, et al.
Publicado: (2020)

Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer
por: Kanda, Mitsuro, et al.
Publicado: (2020)

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
por: Miyashita, Hiroki, et al.
Publicado: (2011)

Knockout of Vasohibin-1 Gene in Mice Results in Healthy Longevity with Reduced Expression of Insulin Receptor, Insulin Receptor Substrate 1, and Insulin Receptor Substrate 2 in Their White Adipose Tissue
por: Takeda, Eichi, et al.
Publicado: (2017)

Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides
por: Yoshida, Tokuyuki, et al.
Publicado: (2022)

Ca(2+) enrichment in culture medium potentiates effect of oligonucleotides
por: Hori, Shin-ichiro, et al.
Publicado: (2015)

Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes
por: Setoguchi, Kiyoko, et al.
Publicado: (2017)

Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides
por: Mori, Shohei, et al.
Publicado: (2017)

Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide
por: Tanaka, Keisuke, et al.
Publicado: (2020)

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model
por: Masuda, Kana, et al.
Publicado: (2018)

Evaluation of off‐target effects of gapmer antisense oligonucleotides using human cells
por: Yoshida, Tokuyuki, et al.
Publicado: (2019)

Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry
por: Terada, Chisato, et al.
Publicado: (2023)

Chimeric Antisense Oligonucleotide Conjugated to α-Tocopherol
por: Nishina, Tomoko, et al.
Publicado: (2015)

Vasohibin‐1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction
por: Watatani, Hiroyuki, et al.
Publicado: (2014)

Vasohibin‐1 expression inhibits advancement of ovarian cancer producing various angiogenic factors
por: Takahashi, Yoshifumi, et al.
Publicado: (2016)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k2aesmsb60m87qcged5s368d4d